1don MSN
Multi-registry study highlights ocrelizumab's superior relapse control in multiple sclerosis
New research presented at the 41st Congress of the European Committee for Treatment and Research in Multiple Sclerosis ...
The study develops a climate-economy model focusing on three sources of ambiguity: climate sensitivity, climate-related economic damage, and abatement cost-effectiveness. Aversion to climate ...
New research presented at the 41st Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS 2025) demonstrates that ocrelizumab provides superior control of ...
Research funded by the Agency for Healthcare Research and Quality found insufficient evidence to determine the accuracy — or ...
Discover how Barra Risk Factor Analysis evaluates investment risk with over 40 metrics, including earnings growth, to inform market-relative portfolio decisions.
Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results